Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenues $ 31,282 $ 24,643
Cost of revenues 14,306 11,457
Gross profit 16,976 13,186
Operating expenses:    
Personnel 3,042 1,727
Marketing and promotion 643 225
General and administrative 6,228 3,171
Bad debts 14 1,025
Total operating expenses 9,927 6,148
Operating income 7,049 7,038
Non-operating income (expenses):    
Interest expense (313) (1,512)
Interest income 163 34
Loss on obligations settled with equity (1)
Gain (loss) on change in fair value of investment 48 (45)
Other investment income 954
Total non-operating income (expenses), net 852 (1,524)
Income before income taxes 7,901 5,514
Provision for income taxes 3,660 1,204
Net income 4,241 4,310
Net income attributable to noncontrolling interests 53 90
Net income attributable to MariMed Inc. $ 4,188 $ 4,220
Net income per share    
Basic $ 0.01 $ 0.01
Diluted $ 0.01 $ 0.01
Weighted average common shares outstanding    
Basic 334,762,825 305,212,269
Diluted 378,890,365 340,825,940